Industry Research Reports

Home > Reports > Medical Care > Global Tuberculosis (TB) Diagnostics Market Insights, Forecast to 2031

Global Tuberculosis (TB) Diagnostics Market Insights, Forecast to 2031

Industry: Medical Care

Published Date: 2025-06-22

Pages: 121 Pages

Report ld: 4772099

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Tuberculosis (TB) Diagnostics Market Size(US$)

CAGR 2025-2031

4.5%

Market Size,2031

USD 4,149

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 3,186 million

Market Forecast in 2031(Value)

US$ 4,149 million

CAGR

4.5%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Tuberculosis (TB) Diagnostics market is projected to grow from US$ 3186 million in 2025 to US$ 4149 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

The global TB diagnostics market is being propelled by the urgent need to improve disease detection and control in response to the persistent burden of tuberculosis, particularly in high-prevalence regions. Efforts to reach WHO’s End TB goals have elevated funding for TB programs, driving the rollout of advanced diagnostic tools like molecular assays , X‑ray based screening solutions with AI assistance, and point-of-care tests. Furthermore, increasing integration of TB screening within broader healthcare initiatives—such as universal healthcare coverage and integrated respiratory disease programs—has expanded testing capacity. The push to screen high-risk populations, including people living with HIV, healthcare workers, migrants, and prison inmates, has also increased demand for rapid, accurate, and decentralized diagnostic methods capable of delivering same-day results and guiding treatment decisions.

Despite significant advancements in TB diagnostics, substantial barriers continue to hinder market expansion. One major challenge is inconsistent access to cutting-edge diagnostic tools in low- and middle-income countries, where infrastructure remains limited and centralized laboratory systems struggle to support widespread deployment. Additionally, the cost of advanced molecular and imaging technologies remains a deterrent, particularly when factoring in expenses for equipment maintenance, consumables, and the specialized training required for healthcare personnel. The regulatory and logistical complexities involved in distributing diagnostic platforms—especially in remote rural areas—also slow down adoption. Finally, the co-existence of disparate diagnostic algorithms across countries, combined with variable healthcare funding and weak supply chain systems, continues to limit consistent implementation of guideline-compliant testing and undermines efforts to significantly reduce TB incidence.

Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%. APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.

In terms of production side, this report researches the Tuberculosis (TB) Diagnostics production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.

In terms of consumption side, this report focuses on the sales of Tuberculosis (TB) Diagnostics by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.

This report presents an overview of global market for Tuberculosis (TB) Diagnostics, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Tuberculosis (TB) Diagnostics, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Tuberculosis (TB) Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tuberculosis (TB) Diagnostics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Tuberculosis (TB) Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Tuberculosis (TB) Diagnostics sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux, Hain Lifescience, Oxford Immunotec, etc.

MARKET SEGMENTATION

By Company

Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others

Segment by Application

Diagnostic Laboratories
Hospitals

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Tuberculosis (TB) Diagnostics production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of Tuberculosis (TB) Diagnostics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Tuberculosis (TB) Diagnostics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: China by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tuberculosis (TB) Diagnostics sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Culture-Based Diagnostics

1.2.3 Sputum Smear Microscopy

1.2.4 Rapid Molecular Diagnostics

1.2.5 Others

1.3 Market by Application

1.3.1 Global Tuberculosis (TB) Diagnostics Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Diagnostic Laboratories

1.3.3 Hospitals

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tuberculosis (TB) Diagnostics Market Perspective (2020-2031)

2.2 Global Tuberculosis (TB) Diagnostics Growth Trends by Region

2.2.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Tuberculosis (TB) Diagnostics Market Size by Region (2020-2031)

2.3 Tuberculosis (TB) Diagnostics Market Dynamics

2.3.1 Tuberculosis (TB) Diagnostics Industry Trends

2.3.2 Tuberculosis (TB) Diagnostics Market Drivers

2.3.3 Tuberculosis (TB) Diagnostics Market Challenges

2.3.4 Tuberculosis (TB) Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Tuberculosis (TB) Diagnostics by Players

3.1.1 Global Tuberculosis (TB) Diagnostics Revenue by Players (2020-2025)

3.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Tuberculosis (TB) Diagnostics, Ranking by Revenue, 2023 VS 2024 VS 2025

3.4 Global Market Concentration Ratio

3.4.1 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Diagnostics Revenue in 2024

3.5 Global Key Players of Tuberculosis (TB) Diagnostics Head office and Area Served

3.6 Global Key Players of Tuberculosis (TB) Diagnostics, Product and Application

3.7 Global Key Players of Tuberculosis (TB) Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

4.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2026-2031)

5 Breakdown Data by Application

5.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Tuberculosis (TB) Diagnostics Market Size (2020-2031)

6.2 North America Market Size by Type

6.2.1 North America Tuberculosis (TB) Diagnostics Market Size by Type (2020-2031)

6.2.2 North America Tuberculosis (TB) Diagnostics Market Share by Type (2020-2031)

6.3 North America Market Size by Application

6.3.1 North America Tuberculosis (TB) Diagnostics Market Size by Application (2020-2031)

6.3.2 North America Tuberculosis (TB) Diagnostics Market Share by Application (2020-2031)

6.4 North America Market Size by Country

6.4.1 North America Tuberculosis (TB) Diagnostics Market Size by Country: 2020 VS 2024 VS 2031

6.4.2 North America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2031)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Tuberculosis (TB) Diagnostics Market Size (2020-2031)

7.2 Europe Market Size by Type

7.2.1 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2020-2031)

7.2.2 Europe Tuberculosis (TB) Diagnostics Market Share by Type (2020-2031)

7.3 Europe Market Size by Application

7.3.1 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2020-2031)

7.3.2 Europe Tuberculosis (TB) Diagnostics Market Share by Application (2020-2031)

7.4 Europe Market Size by Country

7.4.1 Europe Tuberculosis (TB) Diagnostics Market Size by Country: 2020 VS 2024 VS 2031

7.4.2 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Tuberculosis (TB) Diagnostics Market Size (2020-2031)

8.2 China Market Size by Type

8.2.1 China Tuberculosis (TB) Diagnostics Market Size by Type (2020-2031)

8.2.2 China Tuberculosis (TB) Diagnostics Market Share by Type (2020-2031)

8.3 China Market Size by Application

8.3.1 China Tuberculosis (TB) Diagnostics Market Size by Application (2020-2031)

8.3.2 China Tuberculosis (TB) Diagnostics Market Share by Application (2020-2031)

9 Asia (excluding China)

9.1 Asia Tuberculosis (TB) Diagnostics Market Size (2020-2031)

9.2 Asia Market Size by Type

9.2.1 Asia Tuberculosis (TB) Diagnostics Market Size by Type (2020-2031)

9.2.2 Asia Tuberculosis (TB) Diagnostics Market Share by Type (2020-2031)

9.3 Asia Market Size by Application

9.3.1 Asia Tuberculosis (TB) Diagnostics Market Size by Application (2020-2031)

9.3.2 Asia Tuberculosis (TB) Diagnostics Market Share by Application (2020-2031)

9.4 Asia Market Size by Region

9.4.1 Asia Tuberculosis (TB) Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

9.4.2 Asia Tuberculosis (TB) Diagnostics Market Size by Region (2020-2031)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

9.4.8 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Tuberculosis (TB) Diagnostics Market Size (2020-2031)

10.2 Middle East, Africa, and Latin America Market Size by Type

10.2.1 Middle East, Africa, and Latin America Tuberculosis (TB) Diagnostics Market Size by Type (2020-2031)

10.2.2 Middle East, Africa, and Latin America Tuberculosis (TB) Diagnostics Market Share by Type (2020-2031)

10.3 Middle East, Africa, and Latin America Market Size by Application

10.3.1 Middle East, Africa, and Latin America Tuberculosis (TB) Diagnostics Market Size by Application (2020-2031)

10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)

10.4 Middle East, Africa, and Latin America Market Size by Country

10.4.1 Middle East, Africa, and Latin America Tuberculosis (TB) Diagnostics Market Size by Country: 2020 VS 2024 VS 2031

10.4.2 Middle East, Africa, and Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2020-2031)

10.4.3 Brazil

10.4.4 Mexico

10.4.5 Turkey

10.4.6 Saudi Arabia

10.4.7 Israel

10.4.8 GCC Countries

11 Key Players Profiles

11.1 Danaher

11.1.1 Danaher Company Details

11.1.2 Danaher Business Overview

11.1.3 Danaher Tuberculosis (TB) Diagnostics Introduction

11.1.4 Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.1.5 Danaher Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Tuberculosis (TB) Diagnostics Introduction

11.2.4 Roche Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.2.5 Roche Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Introduction

11.3.4 Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 BD

11.4.1 BD Company Details

11.4.2 BD Business Overview

11.4.3 BD Tuberculosis (TB) Diagnostics Introduction

11.4.4 BD Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.4.5 BD Recent Development

11.5 Abbott

11.5.1 Abbott Company Details

11.5.2 Abbott Business Overview

11.5.3 Abbott Tuberculosis (TB) Diagnostics Introduction

11.5.4 Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.5.5 Abbott Recent Development

11.6 Hologic

11.6.1 Hologic Company Details

11.6.2 Hologic Business Overview

11.6.3 Hologic Tuberculosis (TB) Diagnostics Introduction

11.6.4 Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.6.5 Hologic Recent Development

11.7 Qiagen

11.7.1 Qiagen Company Details

11.7.2 Qiagen Business Overview

11.7.3 Qiagen Tuberculosis (TB) Diagnostics Introduction

11.7.4 Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.7.5 Qiagen Recent Development

11.8 BioMerieux

11.8.1 BioMerieux Company Details

11.8.2 BioMerieux Business Overview

11.8.3 BioMerieux Tuberculosis (TB) Diagnostics Introduction

11.8.4 BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.8.5 BioMerieux Recent Development

11.9 Hain Lifescience

11.9.1 Hain Lifescience Company Details

11.9.2 Hain Lifescience Business Overview

11.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Introduction

11.9.4 Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.9.5 Hain Lifescience Recent Development

11.10 Oxford Immunotec

11.10.1 Oxford Immunotec Company Details

11.10.2 Oxford Immunotec Business Overview

11.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Introduction

11.10.4 Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

11.10.5 Oxford Immunotec Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Culture-Based Diagnostics

Table 3. Key Players of Sputum Smear Microscopy

Table 4. Key Players of Rapid Molecular Diagnostics

Table 5. Key Players of Others

Table 6. Global Tuberculosis (TB) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Market Size by Region (2020-2031) & (US$ Million)

Table 9. Global Tuberculosis (TB) Diagnostics Market Share by Region (2020-2031)

Table 10. Market Trends

Table 11. Market Drivers

Table 12. Market Challenges

Table 13. Market Restraints

Table 14. Global Tuberculosis (TB) Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Tuberculosis (TB) Diagnostics Market Share by Players (2020-2025)

Table 16. Global Top Tuberculosis (TB) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2024)

Table 17. Global Tuberculosis (TB) Diagnostics Industry Ranking 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Tuberculosis (TB) Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Tuberculosis (TB) Diagnostics, Headquarters and Area Served

Table 20. Global Key Players of Tuberculosis (TB) Diagnostics, Product and Application

Table 21. Global Key Players of Tuberculosis (TB) Diagnostics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)

Table 25. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2026-2031)

Table 27. Global Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)

Table 29. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2026-2031)

Table 31. North America Market Size by Type (2020-2031) & (US$ Million)

Table 32. North America Market Size by Application (2020-2031) & (US$ Million)

Table 33. North America Tuberculosis (TB) Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Market Size by Country (2020-2031) & (US$ Million)

Table 35. Europe Market Size by Type (2020-2031) & (US$ Million)

Table 36. Europe Market Size by Application (2020-2031) & (US$ Million)

Table 37. Europe Tuberculosis (TB) Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Market Size by Country (2020-2025) & (US$ Million)

Table 39. China Market Size by Type (2020-2031) & (US$ Million)

Table 40. China Market Size by Application (2020-2031) & (US$ Million)

Table 41. Asia Market Size by Type (2020-2031) & (US$ Million)

Table 42. Asia Market Size by Application (2020-2025) & (US$ Million)

Table 43. Asia Tuberculosis (TB) Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 44. Asia Market Size by Region (2020-2031) & (US$ Million)

Table 45. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)

Table 46. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)

Table 47. Middle East, Africa, and Latin America Tuberculosis (TB) Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)

Table 49. Danaher Company Details

Table 50. Danaher Business Overview

Table 51. Danaher Tuberculosis (TB) Diagnostics Product

Table 52. Danaher Revenue (2020-2025) & (US$ Million)

Table 53. Danaher Recent Development

Table 54. Roche Company Details

Table 55. Roche Business Overview

Table 56. Roche Tuberculosis (TB) Diagnostics Product

Table 57. Roche Revenue (2020-2025) & (US$ Million)

Table 58. Roche Recent Development

Table 59. Thermo Fisher Scientific Company Details

Table 60. Thermo Fisher Scientific Business Overview

Table 61. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product

Table 62. Thermo Fisher Scientific Revenue (2020-2025) & (US$ Million)

Table 63. Thermo Fisher Scientific Recent Development

Table 64. BD Company Details

Table 65. BD Business Overview

Table 66. BD Tuberculosis (TB) Diagnostics Product

Table 67. BD Revenue (2020-2025) & (US$ Million)

Table 68. BD Recent Development

Table 69. Abbott Company Details

Table 70. Abbott Business Overview

Table 71. Abbott Tuberculosis (TB) Diagnostics Product

Table 72. Abbott Revenue (2020-2025) & (US$ Million)

Table 73. Abbott Recent Development

Table 74. Hologic Company Details

Table 75. Hologic Business Overview

Table 76. Hologic Tuberculosis (TB) Diagnostics Product

Table 77. Hologic Revenue (2020-2025) & (US$ Million)

Table 78. Hologic Recent Development

Table 79. Qiagen Company Details

Table 80. Qiagen Business Overview

Table 81. Qiagen Tuberculosis (TB) Diagnostics Product

Table 82. Qiagen Revenue (2020-2025) & (US$ Million)

Table 83. Qiagen Recent Development

Table 84. BioMerieux Company Details

Table 85. BioMerieux Business Overview

Table 86. BioMerieux Tuberculosis (TB) Diagnostics Product

Table 87. BioMerieux Revenue (2020-2025) & (US$ Million)

Table 88. BioMerieux Recent Development

Table 89. Hain Lifescience Company Details

Table 90. Hain Lifescience Business Overview

Table 91. Hain Lifescience Tuberculosis (TB) Diagnostics Product

Table 92. Hain Lifescience Revenue (2020-2025) & (US$ Million)

Table 93. Hain Lifescience Recent Development

Table 94. Oxford Immunotec Company Details

Table 95. Oxford Immunotec Business Overview

Table 96. Oxford Immunotec Tuberculosis (TB) Diagnostics Product

Table 97. Oxford Immunotec Revenue (2020-2025) & (US$ Million)

Table 98. Oxford Immunotec Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 2. Global Tuberculosis (TB) Diagnostics Market Share by Type: 2024 VS 2031

Figure 3. Culture-Based Diagnostics Features

Figure 4. Sputum Smear Microscopy Features

Figure 5. Rapid Molecular Diagnostics Features

Figure 6. Others Features

Figure 7. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Global Tuberculosis (TB) Diagnostics Market Share by Application: 2024 VS 2031

Figure 9. Diagnostic Laboratories Case Studies

Figure 10. Hospitals Case Studies

Figure 11. Tuberculosis (TB) Diagnostics Report Years Considered

Figure 12. Global Tuberculosis (TB) Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Tuberculosis (TB) Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Tuberculosis (TB) Diagnostics Market Share by Region: 2024 VS 2031

Figure 15. Global Tuberculosis (TB) Diagnostics Market Share by Players in 2024

Figure 16. Global Top Tuberculosis (TB) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Tuberculosis (TB) Diagnostics Revenue in 2024

Figure 18. North America Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Tuberculosis (TB) Diagnostics Market Share by Type (2020-2031)

Figure 20. North America Tuberculosis (TB) Diagnostics Market Share by Application (2020-2031)

Figure 21. North America Tuberculosis (TB) Diagnostics Market Share by Country (2020-2031)

Figure 22. United States Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Tuberculosis (TB) Diagnostics Market Share by Type (2020-2031)

Figure 26. Europe Tuberculosis (TB) Diagnostics Market Share by Application (2020-2031)

Figure 27. Europe Tuberculosis (TB) Diagnostics Market Share by Country (2020-2031)

Figure 28. Germany Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. China Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. China Tuberculosis (TB) Diagnostics Market Share by Type (2020-2031)

Figure 36. China Tuberculosis (TB) Diagnostics Market Share by Application (2020-2031)

Figure 37. Asia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia Tuberculosis (TB) Diagnostics Market Share by Type (2020-2031)

Figure 39. Asia Tuberculosis (TB) Diagnostics Market Share by Application (2020-2031)

Figure 40. Asia Tuberculosis (TB) Diagnostics Market Share by Region (2020-2031)

Figure 41. Japan Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. South Korea Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. China Taiwan Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Southeast Asia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. India Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Australia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Tuberculosis (TB) Diagnostics Market Share by Type (2020-2031)

Figure 49. Middle East, Africa, and Latin America Tuberculosis (TB) Diagnostics Market Share by Application (2020-2031)

Figure 50. Middle East, Africa, and Latin America Tuberculosis (TB) Diagnostics Market Share by Country (2020-2031)

Figure 51. Brazil Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Mexico Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Turkey Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Israel Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. GCC Countries Tuberculosis (TB) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Danaher Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 58. Roche Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 60. BD Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 61. Abbott Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 62. Hologic Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 63. Qiagen Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 64. BioMerieux Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 65. Hain Lifescience Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 66. Oxford Immunotec Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Tuberculosis (TB) Diagnostics market size from 2025 to 2031? zhanKai

The annual compound growth rate of the global Tuberculosis (TB) Diagnostics market is 4.5% 2025 to 2031.

Which region is expected to have the highest market share? shouQi

What was the global market size of Tuberculosis (TB) Diagnostics in 2025? shouQi

Which companies rank high in the global Tuberculosis (TB) Diagnostics market? shouQi

What was the global market size of Tuberculosis (TB) Diagnostics in 2031? shouQi

Related Reports

Global Tuberculosis (TB) Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Tuberculosis (TB) Diagnostics market size was US$ 3186 million in 2025 and is forecast to reach a readjusted size of US$ 4318 million by 2032 with a CAGR of 4.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 76
USD 4250.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Market Research Report 2026
The global Tuberculosis (TB) Diagnostics market was valued at US$ 3186 million in 2025 and is anticipated to reach US$ 4318 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 2900.00
(Single User License)
Tuberculosis (TB) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 3186 million in 2025 and is projected to reach US$ 4318 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 88
USD 3950.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tuberculosis (TB) Diagnostics market is projected to grow from US$ 3070 million in 2024 to US$ 4149 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 126
USD 4900.00
(Single User License)
Tuberculosis (TB) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 3070 million in 2024 and is forecast to a readjusted size of US$ 4149 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-06-22
Pages: 98
USD 3950.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tuberculosis (TB) Diagnostics market size was US$ 3070 million in 2024 and is forecast to a readjusted size of US$ 4149 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-06-22
Pages: 76
USD 4250.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Market Research Report 2025
The global market for Tuberculosis (TB) Diagnostics was valued at US$ 3070 million in the year 2024 and is projected to reach a revised size of US$ 4149 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Published Date: 2025-06-22
Pages: 74
USD 2900.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Tuberculosis (TB) Diagnostics was estimated to be worth US$ 2870 million and is forecast to reach approximately US$ 3889 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 128
USD 5900.00
(Single User License)
Tuberculosis (TB) Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 2870 million in 2024 and is forecast to a readjusted size of US$ 3889 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 94
USD 3950.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Published Date: 2024-04-17
Pages: 153
USD 5600.00
(Single User License)

Global Tuberculosis (TB) Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Tuberculosis (TB) Diagnostics market size was US$ 3186 million in 2025 and is forecast to reach a readjusted size of US$ 4318 million by 2032 with a CAGR of 4.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 76
USD 4250.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Market Research Report 2026
The global Tuberculosis (TB) Diagnostics market was valued at US$ 3186 million in 2025 and is anticipated to reach US$ 4318 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
USD 2900.00 (Single User License)
Tuberculosis (TB) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 3186 million in 2025 and is projected to reach US$ 4318 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 88
USD 3950.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tuberculosis (TB) Diagnostics market is projected to grow from US$ 3070 million in 2024 to US$ 4149 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 126
USD 4900.00 (Single User License)
Tuberculosis (TB) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 3070 million in 2024 and is forecast to a readjusted size of US$ 4149 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-06-22
Pages: 98
USD 3950.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tuberculosis (TB) Diagnostics market size was US$ 3070 million in 2024 and is forecast to a readjusted size of US$ 4149 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-06-22
Pages: 76
USD 4250.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Market Research Report 2025
The global market for Tuberculosis (TB) Diagnostics was valued at US$ 3070 million in the year 2024 and is projected to reach a revised size of US$ 4149 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Published: 2025-06-22
Pages: 74
USD 2900.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Tuberculosis (TB) Diagnostics was estimated to be worth US$ 2870 million and is forecast to reach approximately US$ 3889 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 128
USD 5900.00 (Single User License)
Tuberculosis (TB) Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 2870 million in 2024 and is forecast to a readjusted size of US$ 3889 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 94
USD 3950.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Published: 2024-04-17
Pages: 153
USD 5600.00 (Single User License)